<DOC>
	<DOCNO>NCT02179606</DOCNO>
	<brief_summary>This study verify Dermalax Implant Plus inferior reference device , RestylaneÂ® Sub-Q , term efficacy safety correction nasolabial fold</brief_summary>
	<brief_title>Clinical Study Evaluate Efficacy Safety Dermalax Implant Plus</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Male female subject younger 30 75 year age . 2 . Subjects score 3 4 Wrinkle Severity Rating Scale ( WSRS ) want improve appearance nasolabial fold ( subject need score side . * ) *The score need side , two nasolabial fold symmetry range 34 . 3 . Subjects symmetric nasolabial fold . 1 . Subjects receive antithrombotic agent within 2 week prior screen ( exception low dose Aspirin le 300 mg/day ) 2 . Subjects history bleed disorder . 3 . Subjects receive calcium hydroxyapatite , CaHA injection nasolabial area .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>